Marker Therapeutics, Inc. - COM (MRKR)

Historical Portfolio Holders from Q3 2018 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
70.7K
Holdings value Q2 2024
$384K
Value change Q2 2024
$0
Grand Portfolio weight change Q2 2024
0%
Number of holders
1
Number of buys Q2 2024
0
Number of sells Q2 2024
0
Average buys Q2 2024 %
0
Average sells Q2 2024 %
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 70.7K $384K $0 $5.43 1
2024 Q1 70.7K $304K $0 $4.30 1
2023 Q4 70.7K $389K $0 $5.50 1
2023 Q3 70.7K $321K +$136K $4.54 1
2023 Q2 40.7K $126K -$223K $3.10 1
2023 Q1 355K $252K -$6.33M $0.71 2
2022 Q4 19.5M $5.21M -$196K $0.27 43
2022 Q3 20.4M $7.54M -$659K $0.37 37
2022 Q2 22.3M $7.34M -$412K $0.33 40
2022 Q1 23.3M $10.3M -$2.49M $0.44 43
2021 Q4 26.5M $25.1M -$1.34M $0.95 60
2021 Q3 26.4M $44.6M -$1.7M $1.69 59
2021 Q2 27.2M $75.8M +$4.1M $2.79 69
2021 Q1 25.4M $56.9M +$25.8M $2.24 72
2020 Q4 14.1M $20.4M -$85.2K $1.45 57
2020 Q3 14.1M $21.2M -$280K $1.50 57
2020 Q2 14.2M $29.4M -$1.43M $2.07 60
2020 Q1 14.9M $28.3M -$1.43M $1.90 59
2019 Q4 15.4M $44.5M -$10.9M $2.88 63
2019 Q3 17.1M $87.6M -$1.57M $5.11 71
2019 Q2 16.9M $134M +$13.4M $7.92 68
2019 Q1 15.3M $101M -$154K $6.60 53
2018 Q4 15.6M $86.4M +$75.2M $5.55 41
2018 Q3 3.56K $32K +$32K $8.98 1